Tracy Zimmermann
Chief Scientific OfficerDr. Tracy Zimmermann, Ph.D., is Chief Scientific Officer of City Therapeutics, Inc. since May 2024. Dr. Zimmermann was Chief Development Officer at Generation Bio Co. since November 9, 2020 until January 28, 2024. Dr. Zimmermann previously served as Vice President of Preclinical Research and translational biology at Generation Bio Co. from October 2018 to November 2020. Prior to joining the Generation Bio Co. she held a variety of R&D roles over a 15-year tenure at Alnylam Pharmaceuticals. From January 2012 until September 2018, Dr. Zimmermann was a research director at Alnylam Pharmaceuticals, Inc. Dr. Zimmermann earned a B.S. degree in biochemistry from Lehigh University and a Ph.D. in chemistry from the University of Colorado at Boulder.
Positions
- Company NameCity Therapeutics, Inc.Stock CodeCTYPositionChief Scientific Officer
